Putnam Investments’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,868
Closed -$2.07M 1225
2022
Q3
$2.07M Sell
100,868
-2,678
-3% -$76.5K ﹤0.01% 721
2022
Q2
$3.3M Sell
103,546
-21,671
-17% -$817K 0.01% 610
2022
Q1
$5.24M Buy
125,217
+2,502
+2% +$105K 0.01% 489
2021
Q4
$5.48M Buy
122,715
+332
+0.3% +$16K 0.01% 509
2021
Q3
$6.01M Sell
122,383
-17,718
-13% -$923K 0.01% 475
2021
Q2
$7.37M Buy
140,101
+34,535
+33% +$1.73M 0.01% 438
2021
Q1
$4.86M Hold
105,566
0.01% 502
2020
Q4
$5.02M Buy
105,566
+19,316
+22% +$922K 0.01% 499
2020
Q3
$3.83M Hold
86,250
0.01% 528
2020
Q2
$3.35M Sell
86,250
-69,688
-45% -$2.82M 0.01% 540
2020
Q1
$6.42M Buy
+155,938
New +$7.47M 0.02% 398

Other funds holding ELAT

Putnam Investments's ELAT Position: Q4 2022 in Review

Putnam Investments sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q4 2022, closing a stake of 100,868 shares — an estimated $2.07M sold.

Putnam Investments first reported a position in ELAT in Q1 2020 and held it in 11 quarters. The position peaked at $7.37M in Q2 2021. 27 funds tracked by Wall St. Rank hold ELAT as of Q4 2022.

  • Putnam Investments reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q4 2022 after selling out during the quarter.
  • Putnam Investments sold 100,868 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q4 2022, an estimated $2.07M.
  • Putnam Investments first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 11 quarters.
  • Putnam Investments's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $7.37M in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q4 2022.

Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.